The St. Baldrick's Foundation has awarded our research team a one year grant for the study, "Reversal of Shh-Driven Medulloblastoma by Proteasome Inhibitors". This is an exciting award for this therapeutics project that follows the initial mouse brain tumor model developed in as an award from the Pediatric Brain Tumor Foundation. This new project is being led by postdoctoral fellow, Eri Taniguchi, PhD.
